An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.

Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin. AAPS PharmSciTech (2007) 0.90

The puzzle of overactive bladder: controversies, inconsistencies, and insights. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.87

Oxybutynin extended release for the management of overactive bladder: a clinical review. Drug Des Devel Ther (2009) 0.80

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther (1999) 2.18